Skip to main content

Table 1 In-/exclusion criteria

From: The effect of Bosentan on exercise capacity in Fontan patients; rationale and design for the TEMPO study

Inclusion criteria

•

Fontan/TCPC operated

•

Expected clinical stability > 3 months, evaluated by investigator from clinical record

Exclusion criteria

•

Age < 12 years

•

Severe heart failure (NYHA-class IV)

•

Oxygen saturation < 85% at rest

•

Pre-existing liver condition (transaminases 2x > upper reference limit)

•

Renal failure (creatinin > 150 mmol/l)

•

Restrictive Fontan circuit

•

History of work induced severe arrhythmia

•

Systolic blood pressure below 80% of reference (< 88 mmHg)

•

Use of any of following drugs: Fluconazole, Ketoconazole, CyclosporineA, Lopinavir, Ritonavir, Rifampicin, Carbamazepine and Phenytoin

•

Severe extra-cardiac condition e.g. neurological impairment

•

For women: Positive HCG or no use of contraception*

•

History of low compliance

  1. TCPC: Total Cavo-Pulmonary Connection, NYHA: New York Heart Association, HCG: Human Chorionic Gonadotropin, *: contraception includes celibacy.